©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Dyrk, a Dual Specificity Protein Kinase with Unique Structural Features Whose Activity Is Dependent on Tyrosine Residues between Subdomains VII and VIII (*)

(Received for publication, June 23, 1995; and in revised form, November 8, 1995)

Heiner Kentrup (§) Walter Becker (§) Jörg Heukelbach Anja Wilmes Annette Schürmann Christine Huppertz Heikki Kainulainen (¶) Hans-Georg Joost (**)

From the Institut für Pharmakologie und Toxikologie, Rheinisch-Westfälische Technische Hochschule Aachen, D-52057 Aachen, Federal Republic of Germany

ABSTRACT
INTRODUCTION
MATERIAL AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

The cDNA of a novel, ubiquitously expressed protein kinase (Dyrk) was cloned from a rat brain cDNA library. The deduced amino acid sequence (763 amino acids) contains a catalytic domain that is only distantly related to that of other mammalian protein kinases. Its closest relative is the protein kinase Mnb of Drosophila, which is presumably involved in postembryonic neurogenesis (85% identical amino acids within the catalytic domain). Outside the catalytic domain, the sequence comprises several striking structural features: a bipartite nuclear translocation signal, a tyrosine-rich hydrophilic motif flanking the nuclear localization signal, a PEST region, a repeat of 13 histidines, a repeat of 17 serine/threonine residues, and an alternatively spliced insertion of nine codons. A recombinant glutathione S-transferase-Dyrk fusion protein catalyzed autophosphorylation and histone phosphorylation on tyrosine and serine/threonine residues with an apparent K of approximately 3.4 µM. Exchange of two tyrosine residues in the ``activation loop'' between subdomains VII and VIII for phenylalanine almost completely suppressed the activity and tyrosine autophosphorylation of Dyrk. Tyrosine autophosphorylation was also reduced by exchange of the tyrosine (Tyr-219) in a tyrosine phosphorylation consensus motif. The data suggest that Dyrk is a dual specificity protein kinase that is regulated by tyrosine phosphorylation in the activation loop and might be a component of a signaling pathway regulating nuclear functions.


INTRODUCTION

Reversible phosphorylation of proteins represents the main mechanism of signal transduction in cells (Edelman et al., 1987; Cohen, 1992; Hunter, 1991). It is catalyzed by a large family of protein kinases that share structural similarities (11 subdomains) within a catalytic domain of about 300 amino acids (Hanks et al., 1988). Protein kinases appear to represent the largest family of enzymes (Hunter, 1987), and to date more than 100 mammalian protein kinases have been identified by molecular cloning and/or functional characterization. This large number of homologous proteins provides the basis of a complex signaling network that transmits and coordinates the response to extracellular stimuli.

Two major subgroups of protein kinases, the protein tyrosine kinases and the protein serine/threonine kinases, have been distinguished on the basis of functional but also of structural parameters (Hanks et al., 1988; Hunter, 1991). Initially it was assumed that the members of these subfamilies are specific for phosphorylation of either tyrosine or serine/threonine residues. More recently, however, several kinases have been identified that catalyze their autophosphorylation on both tyrosine and serine/threonine residues when isolated as recombinant proteins from Escherichia coli (Lindberg et al., 1992). In addition, two other kinases have dual specificity toward a specific substrate in vivo, i.e. in the intact cell. The dual specificity kinase MEK1 phosphorylates MAP (^1)kinase/ERK2 on both threonine 183 and tyrosine 185 (Payne et al., 1991), thereby activating the kinase and presumably inducing its translocation to the nucleus. Similarly, the dual specificity kinase Wee1 of Schizosaccharomyces pombe appears to phosphorylate and inhibit the serine/threonine kinase Cdc2 by phosphorylation on tyrosine 15 (Lundgren et al., 1991).

In this paper, we report the cloning and characterization of a novel dual specificity protein kinase with unique structural features. The activity of this kinase appears to be regulated by tyrosine phosphorylation in the presumed activation loop between subdomains VII and VIII. Its sequence comprises a nuclear targeting motif, a PEST region, and two striking repeats of unknown function. It is suggested that the enzyme is part of a signaling pathway that controls nuclear functions.


MATERIAL AND METHODS

RNA Preparation and cDNA Synthesis

3T3-L1 cells (Green and Kehinde, 1974) were differentiated as described previously (Weiland et al., 1991), washed twice with phosphate-buffered saline, frozen in liquid nitrogen, and lysed in a solution of 4 M guanidine thiocyanate and 7% mercaptoethanol. Rat tissues were homogenized with a Polytron homogenizer in 4 M guanidine thiocyanate supplemented with 7% mercaptoethanol. The lysates were layered on a cesium chloride cushion (5.88 M) and centrifuged at 28,000 rpm (rotor SW 40) for 29 h at 20 °C. Pelleted RNA was dissolved with 300 µl of 0.1 M sodium acetate/Tris buffer (pH 9.0) and was neutralized by the addition of 50 µl of 2 M potassium acetate (pH 5.5). First strand cDNA was synthesized with reverse transcriptase (First-strand cDNA synthesis kit, Pharmacia Biotech Inc.) by oligo(dT) priming.

PCR Cloning of Protein Serine/Threonine Kinases

Highly degenerate oligonucleotide primers were designed from the conserved regions VIb and IX (according to Hanks and Quinn(1991)) of the catalytic domain of protein serine/threonine kinases. Forward primer, 5`-A(C/T)(A/C)GIGA(C/T)(A/C/T)TIAA(A/G)(C/T)CI(C/G)A(A/G)AA-3`; reverse primer, 5`-A(A/G/T)(A/C/G)A(C/T)ICC(A/C/G)A(A/G)I(A/G)(A/C/T)CCAI(A/C)(A/C/T)(A/G)TC-3`. PCR amplification, separation of the products, and cloning was carried out as described previously (Becker et al., 1994). Plasmid DNA was isolated and characterized by sequencing or Southern blotting.

Library Screening and DNA Sequencing

Cloned PCR products were isolated with restriction enzymes and used as probes to screen a rat fat cell gt11 library (Clontech Laboratories, Palo Alto, CA, catalog no. RL 10011b) and a rat brain -zap cDNA library (Stratagene, La Jolla, CA, catalog no. 937502). Deletions were generated by exonuclease digestion and by sonication (Branson sonifier 450, cup horn, 1 min at maximum setting) and were sequenced by the method of Sanger (T7-sequencing-kit, Pharmacia). Sequences were determined with overlapping fragments from both directions.

Northern Blot Analysis

Samples of total RNA (20 µg) dissolved in a denaturing solution containing formaldehyde (6.5%) and formamide (50%) and incubated at 65 °C for 15 min were separated by electrophoresis through 1% agarose gels containing 6.5% formaldehyde. Gels were stained with ethidium bromide before transfer onto nylon membranes (Hybond, Amersham-Buchler, Braunschweig, Germany) in order to ascertain that equal amounts of total RNA had been separated. Membranes were hybridized at 42 °C with partial cDNA probes labeled with [P]dCTP by random oligonucleotide priming (Feinberg and Vogelstein, 1983). The blots were washed twice at 55 °C in 0.12 M NaCl, 0.012 M sodium citrate, 0.1% SDS and once with 0.015 M NaCl, 0.0015 M sodium citrate, 0.1% SDS.

Preparation of Recombinant GST-Dyrk

A PCR fragment (bp 112-745) of the Dyrk cDNA (clone B) comprising an EcoRI site before the initiation codon was prepared and used for construction of an expression vector pGEX-2TK (Pharmacia) harboring the cDNA of Dyrk (bp 119-2414) fused with that of GST in a single open reading frame. Due to the cloning strategy, the two amino acids before the stop codon were exchanged for a short linker-derived segment. PCR product and fusion domain were verified by sequencing. Site-directed mutagenesis with single-stranded DNA as template was performed as described previously (Kunkel et al., 1987). Mutants were confirmed by sequencing and subcloned into pGEX. Transformants in E. coli DH5alpha were isolated, induced with isopropyl-1-thio-beta-D-galactopyranoside for 2 h at 37 °C, and lysed by sonication. The recombinant fusion protein was purified by affinity adsorption to glutathione-Sepharose and eluted with glutathione as described by the manufacturer (Pharmacia). The concentration of active recombinant kinase was determined by laser densitometry of the Coomassie-stained 90-kDa product in comparison with bovine serum albumin standards.

Expression of Dyrk in COS-7 Cells

The cDNA of Dyrk was subcloned into a derivative of the mammalian expression vector pSVL, which contains a translation start and a short tag sequence for immunochemical detection (HA1 protein of influenza virus). In addition, the C terminus was extended by a short linker-derived segment by the cloning strategy. Transfection of COS-7 cells was performed as described previously (Wandel et al., 1994). For immunochemical detection, cells were lysed by boiling in 1% SDS in 10 mM Tris buffer (pH 7.4). For immunoprecipitation, cells were lysed in buffer containing 50 mM Hepes, 150 mM NaCl, 2 mM EDTA, 20 mM NaF, 2 mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride, 1 mM sodium vanadate, 2 µg/ml aprotinin, 2 µg/ml leupeptin, 1 µg/ml pepstatin, and 1% Nonidet P-40. Antiserum against the HA epitope was from BabCo, Richmond, CA. Immunocomplexes were isolated with protein A-Sepharose, and a kinase assay (see below) was carried with the adsorbed material in the presence of histone. The products were separated by SDS-PAGE and detected by autoradiography.

Autophosphorylation of Recombinant GST-Dyrk Transferred to PVDF Membranes

Samples of the fusion protein were separated by SDS-PAGE and transferred onto PVDF membranes (Immobilon-P, Millipore, United Kingdom). Proteins were denatured and renatured as described previously (Ferrell and Martin, 1991), and the membranes were incubated in 2 ml of phosphorylation buffer consisting of 33 mM Hepes, 6.6 mM manganese chloride, 6.6 mM magnesium chloride, 0.7 mM dithiothreitol, and [P]ATP (40 µCi). Membranes were washed as described by Ferrell and Martin(1991) and autoradiographed for 16 h.

Assay of Protein Kinase Activity

Samples of the fusion proteins were incubated in phosphorylation buffer containing [P]ATP (2 µCi, tracer only or final concentration of 10-100 µM as indicated) in a total volume of 12 µl for 30 min at room temperature. Histone (type IIS, catalog no. H6005, Sigma), alpha-casein (catalog no. C8032), or poly-Glu/Tyr 4:1 (catalog no. P0275) were added to a final concentration of 0.66 µg/µl or as indicated. Thereafter, the samples were boiled with Laemmli's sample buffer (Laemmli, 1970) and separated on 10 or 14% polyacrylamide gels. The gels were dried and autoradiographed for 1-4 h.

Assay of Tyrosine Phosphorylation of GST-Dyrk

Samples of the fusion protein GST-Dyrk were separated on 10% polyacrylamide gels, transferred onto nitrocellulose membranes, and probed with anti-phosphotyrosine antibodies (Transduction laboratories, Nottingham, UK).

Phosphoamino Acid Analysis

Autophosphorylation of recombinant GST-Dyrk was carried out as described above. Reaction products were precipitated with 10% trichloroacetic acid, and hydrolyzed in 5.8 M hydrochloric acid for 2 h at 110 °C. The lysates were dried under nitrogen, washed with water, and dissolved in 10 µl of water supplemented with carrier phosphoamino acids. The phosphoamino acids were separated by thin-layer chromatography (silica gel, 25% ammonium hydroxide, 96% ethanol, 1.6:3.5). In a separate experimental series, phosphorylation was carried out in the presence of histone. The reaction products were separated by SDS-PAGE and transferred onto PVDF membranes. The phosphorylated histone was identified by autoradiography, cut, and hydrolyzed as described above.


RESULTS

Cloning of Dyrk

Degenerate oligonucleotide primers matching the regions VIb and IX according to the nomenclature of Hanks (Hanks and Quinn, 1991) were designed to amplify a domain of about 150 bp, including the activation loop of protein serine/threonine kinases. PCR products were cloned, and 70 clones encoding 13 different sequences were identified as protein kinases by a data base search or on the basis of structural criteria. One of them (PSK47, later designated Dyrk) was chosen for further characterization.

Three hybridizing cDNA clones (A, B, and D) of different lengths were isolated from a rat brain cDNA library and characterized by restriction mapping and/or sequencing. One of these clones (clone B, 5 kilobase pairs) contained a full reading frame and a poly(A) tail. Clone A contained a poly(A) tail but lacked 2.3 kilobase pairs in the 3`-untranslated region; clone D had a deletion of 27 bp within the open reading frame (see below).

Structural Characteristics of Dyrk

The amino acid sequence as depicted in Fig. 1A was deduced from an open reading frame (clone B) in which the translation start was assigned to the first AUG codon after a stop codon. The sequence of clone D differed from that of clone B by a deletion of 27 bp within the open reading frame (codons 69-78, shaded box). In order to confirm that two different RNA species were present in rat brain, the corresponding domain was amplified by PCR with cDNA from rat brain as the template. Indeed, two bands of the expected size were identified (data not shown). Thus, it appears reasonable to conclude that the mRNA of Dyrk is alternatively spliced, generating two products that differ by 27 nucleotides.

Figure 1: Structural characteristics of the dual specificity protein kinase Dyrk. A, nucleotide and deduced amino acid sequence of the cDNA of rat Dyrk. The deduced amino acid sequence of rat Dyrk is given in single-letter code above the respective codons. The catalytic domain is boxed, and the PEST region (dashed underline), a histidine repeat (underline), and a serine/threonine repeat (double underline) are indicated. The shaded box depicts an alternatively spliced segment of the sequence. A putative bipartite nuclear targeting signal is marked by + symbols above the respective residues, and amino acid residues that were later exchanged by site-directed mutagenesis (Lys-188, Tyr-219, Tyr-319, and Tyr-321) are depicted by asterisks. B, schematic presentation of the structure of Dyrk. Boxes depict the position of the different structural motifs and domains in the sequence of Dyrk. The amino acid sequences of the spliced domain, the nuclear targeting signal, and some of the kinase subdomains are given in single-letter code. Roman numerals designate the kinase subdomains according to the nomenclature of Hanks (Hanks and Quinn, 1991).



The deduced amino acid sequence (763 amino acids) contains all conserved regions of the catalytic domain (amino acids 159-479) according to the classification of Hanks (Hanks and Quinn, 1991) (subdomains I-XI, Fig. 1B). In addition, the sequence exhibits several striking characteristics (Fig. 1B). First, the sequence harbors a bipartite nuclear targeting sequence (Robbins et al., 1991; Dingwall and Laskey, 1991) flanking the N-terminal side of the catalytic domain. Second, the amino acid sequence of Dyrk comprises several tyrosine residues that may represent phosphorylation sites. Two tyrosines located between the subdomains VII and VIII are potential phosphorylation sites regulating the activity of the catalytic domain, in analogy to other protein kinases, e.g. ERK/MAPK and GSK3beta (see Fig. 7) (Rossomando et al., 1992; Hughes et al., 1993). Dyrk then contains two other putative consensus motifs of tyrosine phosphorylation (Tyr-112 and Tyr-219), which are preceded by lysine and glutamic acid, 7 or 3 residues to the N-terminal side, respectively (Cooper et al., 1984). In addition, a tyrosine-rich, highly charged motif that contains 4 tyrosines and 5 aspartic acid residues is located between the nuclear targeting domain and the N terminus of the catalytic domain.


Figure 7: Sequence comparison of protein kinases that are regulated by phosphorylation in the presumed activation loop between domains VII and VIII. Amino acids are given in single-letter code; residues identical with the corresponding amino acids in Dyrk are designated by periods. The subdomains VII and VIII are boxed. Asterisks above tyrosines or threonines indicate residues that have been identified as activating phosphorylation sites.



As a third unique structural feature of Dyrk, the large domain flanking the C terminus of the catalytic domain contains several striking motifs. Immediately following the catalytic domain, a serine/threonine-rich region fulfills the requirements of a PEST region. These motifs represent domains abundant in proline, glutamic acid, serine, and threonine and are believed to initiate a rapid degradation of the protein (Rogers et al., 1986). Furthermore, the C terminus of Dyrk harbors a stretch of 13 consecutive histidine residues (amino acids 607-619), and a domain containing an unusually high portion of serine and threonine residues (46 serines out of a total of 284 amino acids). Within the serine/threonine-rich segment is a stretch (amino acids 659-672) of 17 subsequent serine/threonine residues.

Data base searches turned up several partial human and mouse cDNA sequences (expressed sequence tags) with high similarity to the nucleotide sequence of Dyrk. Two of these sequence tags (mouse, accession no. Z31282; human, accession no. L25452) comprise the histidine repeat, indicating that the amino acid sequence of this repeat is fully conserved. The chromosomal localization of the latter sequence tag has been determined (Cheng et al., 1994) by hybridization to a set of mapped YAC's derived from chromosome 21. Based on the high similarity of this sequence tag with Dyrk (95% identical nucleotides), it appears safe to conclude that the chromosomal localization of the human homologue of Dyrk is 21q22.2.

Relationship of Dyrk with Other Kinases

Data bases were searched (SWISS-PROT, the Protein Identification Resource, EMBL data base) in order to find relatives of Dyrk by a comparison of its catalytic domain with that of known protein serine/threonine kinases, and a dendrogram of a selected number of protein kinases was constructed (Fig. 2A). The dendrogram demonstrates that the structure of the catalytic domain of Dyrk differs considerably from that of most other kinases. Its closest relative (85% identical amino acids within the catalytic domain) is encoded by a gene from Drosophila (mnb), which has recently been found disrupted in a mutant with abnormal neurogenesis (minibrain; Tejedor et al.(1995)). The second closest relative (46% identical amino acids) is a partial human sequence (PSK-H2) that was published without further information (Hanks and Quinn, 1991). In addition, a third relative appears to be the 89-kDa protein serine/threonine kinase (Yak1) from yeast (39% identical amino acids), which is believed to inhibit mitosis (Garrett et al., 1991). The dendrogram indicates that Dyrk is located on the same branch of the protein kinase superfamily as Mnb, PSK-H2, and Yak1, but is only distantly related to the other subfamilies. Fig. 2B depicts an alignment of Mnb, PSK-H2, and Yak1 with Dyrk, demonstrating that the identities within this subfamily are mainly restricted to the subdomains I, II, III, V, VIb, VII, VIII, IX, and XI of the catalytic domain. There is no similarity outside the catalytic domains (comparison not shown) except for 70 amino acids flanking the N terminus of the catalytic domain of Mnb. Thus, Dyrk is a novel member of a small subfamily of protein kinases with a unique structure of both the catalytic domain and the flanking N- and C-terminal regions.


Figure 2: Comparison of the catalytic kinase domain of Dyrk with that of other protein kinases. A, dendrogram of an alignment of the catalytic domains of Dyrk and other protein serine/threonine kinases. The dendrogram was constructed with the PILEUP program. Data base accession numbers (Protein Identification Resource) are as follows: Yak1, A32582; CDC2, A29539; CDK4 (cyclin-dependent kinase 4), JN0460; CDK5, A46365; ERK2/MAP-kinase, S16444; GSK3b (glycogen synthase kinase 3beta), S14708; MEK1 (MAPK/ERK-kinase), S29863; PKA (cAMP-dependent protein kinase), S21640; PKC, A26037; TIK, A40813; ESK, A44439. GenBank accession numbers were as follows: Mnb, X70794; Clk1, L29219; Clk2, L29218; Clk3, L29217; P38, L35253; JNK1 (jun-kinase 1), L26318. Asterisks indicate known dual specificity kinases. B, sequence alignment of the catalytic domains of Dyrk, Mnb, PSK-H2, and Yak1. The deduced amino acid sequences of the catalytic domains were aligned with the aid of the CLUSTAL program (gap penalty 5, open gap cost 10, unit gap cost 10). Hyphens represent gaps introduced for optimal alignment, { } indicates a portion of the sequence of PSK-H2 that was not shown in the source (Hanks and Quinn, 1991). The kinase subdomains according to the nomenclature of Hanks (Hanks and Quinn, 1991) are depicted on the top of the alignment by Roman numerals. Residues identical with Dyrk are boxed. Asterisks indicate amino acids identical in all compared sequences; periods designate conservative substitutions. References for the kinases are as follows: Mnb (Tejedor et al., 1995); PSK-H2 (Hanks and Quinn, 1991); Yak1 (Garrett and Broach, 1989).



Expression of Dyrk mRNA in Various Rat Tissues

Northern blot analysis of total RNA from a series of different rat tissues detected two transcripts (2.8 and 5.4 kb) in all tissues examined (brain, heart, skeletal muscle, lung, intestine, fat cells, adrenal gland, testis, thymus, kidney, liver, and spleen; data not shown). These sizes correspond reasonably well with those derived from the isolated clones. Although mRNA levels appeared somewhat different in the various tissues, the data indicate a ubiquitous expression of Dyrk mRNA.

Protein Kinase Activity of Dyrk

In order to demonstrate the protein kinase activity of Dyrk, a recombinant GST-Dyrk fusion protein was expressed in E. coli DH5alpha and was purified by affinity adsorption on glutathione-Sepharose. Analysis of the partially purified fusion protein by SDS-PAGE showed a major product of an apparent molecular mass of 90 kDa and several other bands of higher mobility (60, 41, and 30 kDa; Fig. 3A). All bands appear to be derived from the recombinant GST-Dyrk fusion protein because they were not present in control preparations of GST alone. As judged from the calculated molecular weight of GST-Dyrk (112 kDa), only fragments of the protein kinase were isolated. Variation of the conditions of expression and isolation (temperature, duration of induction, addition of protease inhibitors) failed to prevent the partial degradation of the fusion protein or allow the isolation of a 112-kDa protein. However, the truncated 90-kDa GST-Dyrk exhibited a marked protein kinase activity that was detected after renaturing of the protein on PVDF membranes (Fig. 3B). As is also illustrated in Fig. 3B, the smaller fragments lacked a detectable protein kinase activity. Preliminary experiments were carried out in order to find out which domain(s) were removed from the 90-kDa fragment. Thrombin cleavage of the 90 kDa GST-Dyrk, presumably at the cleavage site engineered in the linker between GST and Dyrk, generated an active kinase of approximately 60 kDa (data not shown). Furthermore, the 90-kDa fragment appeared to cross-react with an antibody against GST. Finally, taking advantage of the histidine repeat, we isolated an active protein kinase by affinity adsorption on nickel-chelating agarose (data not shown). Thus, it is tentatively concluded that the 90-kDa band represents a fragment that comprises both GST-domain and histidine repeat but lacks the remaining part of the C terminus of Dyrk.


Figure 3: Expression of Dyrk as an active protein kinase in E. coli. A, Coomassie stain of the recombinant proteins partially purified by affinity absorption on glutathione-Sepharose and separated on SDS-PAGE (10% gel). GST, transformation of E. coli with vector encoding glutathione S-transferase alone; GST-Dyrk, transformation with vector comprising the coding regions of GST and Dyrk in a single reading frame. B, protein kinase activity of a 90-kDa fragment of Dyrk. The recombinant proteins were separated on SDS-PAGE (10%) and were transferred onto PVDF membranes, renatured, and subjected to an in situ kinase assay. C, phosphorylation of exogenous substrates by Dyrk. The in vitro kinase assay was carried out with partially purified GST-Dyrk in the absence (GST-Dyrk) or presence of the indicated substrates (histone, casein, poly-Glu/Tyr). The reaction products were separated by SDS-PAGE (14%) and subjected to autoradiography.



Fig. 3C illustrates a series of experiments designed to further characterize the protein kinase activity of Dyrk. In vitro protein kinase assays with recombinant Dyrk in the presence of magnesium, manganese, and [P]ATP indicated that the kinase, in addition to autophosphorylating the 90-kDa fragment, stimulated a marked P incorporation into its smaller fragments (Fig. 3C, first lane). Furthermore, the fusion protein catalyzed the P incorporation into histone and casein but failed to phosphorylate the tyrosine kinase substrate poly-Glu/Tyr. A quantitative assessment of the stoichiometry of autophosphorylation of the 90 kDa band (Fig. 3C, first lane) indicated that 1 mol of phosphate was incorporated per 8 mol of recombinant protein kinase, suggesting that the protein was already phosphorylated in E. coli (see Fig. 5A).


Figure 5: Dual specificity protein kinase activity of Dyrk: autophosphorylation and histone phosphorylation on tyrosine and serine/threonine residues. A, tyrosine autophosphorylation of the 90-kDa fragment of Dyrk as detected with anti-phosphotyrosine antibody. Partially purified GST-Dyrk was separated by SDS-PAGE (10% gel) and transferred onto a nitrocellulose membrane, and phosphotyrosine was detected immunochemically with specific antiserum. B, detection of phosphotyrosine in hydrolysates of phosphorylated GST-Dyrk. Partially purified GST-Dyrk was subjected to an in vitro autophosphorylation in the presence of [P]ATP. The reaction products were hydrolyzed and separated by thin-layer chromatography as described under ``Materials and Methods.'' The positions of carrier phosphotyrosine (PY) and phosphoserine/phosphothreonine (PS/PT) as determined by ninhydrine staining are marked. C and D, tyrosine phosphorylation of histone by Dyrk. Histone was phosphorylated by partially purified Dyrk in the presence of the indicated bivalent ions or EDTA. The reaction products were separated by SDS-PAGE and subjected to autoradiography (C). D, additional samples prepared by the same procedure were transferred onto PVDF membranes (14% gel, right panel). The phosphorylated 13 kDa band was cut out of the membrane and hydrolyzed. Aliquots adjusted for their content of radioactivity were separated by thin-layer chromatography and subjected to autoradiography.



Expression of Dyrk in COS-7 Cells

COS-7 cells were transiently transfected with a construct comprising the Dyrk cDNA fused to the HA tag for immunochemical detection. Western blotting of total cell lysate (Fig. 4A) identified an immunoreactive product of 105 kDa, which was absent in controls transfected with blank vector. As is illustrated in Fig. 4B, the immunoprecipitated product of the transfection catalyzed its autophosphorylation as well as phosphorylation of histone. It should be noted that the calculated molecular weight of the HA-Dyrk construct (90.5 kDa) is somewhat lower than the observed molecular mass.


Figure 4: Expression of Dyrk in COS-7 cells. COS-7 cells were transiently transfected with a Dyrk construct (HA-Dyrk) or blank vector (Control) as described. A, cells were boiled with SDS, and lysates were separated by SDS-PAGE (10%), transferred onto nitrocellulose, and probed with anti-HA antiserum. B, cells were lysed with Nonidet P-40, and HA-Dyrk was isolated by immunoprecipitation. The immunocomplexes were subjected to a kinase assay in the presence of histone and separated by SDS-PAGE, and the incorporated P was detected by autoradiography.



Dual Specificity Protein Kinase Activity of Dyrk

Since the sequence of Dyrk harbors two consensus motifs for tyrosine phosphorylation, we studied the possibility that Dyrk was autophosphorylated on tyrosine residues or catalyzed the tyrosine phosphorylation of histone. The GST-Dyrk preparation was partially purified, separated by SDS-PAGE, and transferred onto nitrocellulose membranes. Probing with anti-phosphotyrosine antibody (Fig. 5A) revealed that the 90-kDa fragment indeed contained phosphotyrosine. In addition, a second, much weaker immunoreactive band was detected at approximately 41 kDa. Since E. coli is devoid of tyrosine kinase activities (Kornbluth et al., 1988), the tyrosine phosphorylation of GST-Dyrk must result from its autophosphorylating activity. In order to confirm the identity of the phosphotyrosine by an analysis of the phosphorylated amino acids, GST-Dyrk was in vitro phosphorylated by [P]ATP and hydrolyzed, and the hydrolysate was separated by thin-layer chromatography (Fig. 5B). As anticipated, phosphotyrosine as well as phosphoserine/phosphothreonine were detected. In addition, hydrolysis and amino acid analysis of histone (11-15 kDa), which was phosphorylated by Dyrk revealed that the kinase catalyzed a marked tyrosine phosphorylation of the exogenous substrate (Fig. 5, C and D).

It was reported previously that the serine kinase phosphorylase kinase exhibited a tyrosine kinase activity toward angiotensin II in the presence of manganese (Yuan et al., 1993). Thus, we studied the dependence of both total and tyrosine phosphorylating activity of Dyrk on bivalent ions (Fig. 5C). Magnesium alone was sufficient for the total protein kinase activity but was much less effective than manganese; EDTA fully suppressed the kinase activity of Dyrk. The tyrosine kinase activity of Dyrk does not appear to require the presence of manganese, since the ratio of phosphotyrosine to phosphoserine/threonine was identical with both bivalent ions (Fig. 5D).

In order to further characterize the protein kinase activity of Dyrk, a preliminary kinetic analysis of the histone phosphorylation was performed (Fig. 6). The K(m) value of the total phosphorylation reaction obtained in the presence of 40 µM ATP was 0.044 µg/µl or 3.4 µM (slope of the Lineweaver-Burke plot as determined by linear regression: 2.01 ± 0.14 (min times µg)/(pmol times µl)). Since mainly one component of the histone preparation was phosphorylated, the true K(m) for phosphorylation of this isotype is even lower and was estimated to be less than 2 µM. V(max) was 2.2 nmol/(min times mg) (ordinate intercept, 45.9 ± 8.8 min/pmol). At all tested histone concentrations, more phosphotyrosine was detected than phosphoserine (Fig. 6, inset). Moreover, the ratio of phosphotyrosine to phosphoserine was not altered at different histone concentrations, indicating similar K(m) values of both reactions. Thus, the data warrant the conclusion that Dyrk is a dual specificity kinase, phosphorylating both tyrosine and serine/threonine residues in its sequence and in exogenous substrates.


Figure 6: Kinetic analysis of the phosphorylation of histone by Dyrk. Samples of recombinant Dyrk (10 ng/10 µl) were incubated at room temperature for 10 min in phosphorylation buffer containing the indicated concentrations of histone and [-P]ATP (final concentration, 40 µM). The samples were separated by SDS-PAGE, and the radioactivity incorporated was determined by cutting and scintillation counting of the histone band. Linear regression analysis of the Lineweaver-Burke plot yielded a slope of 2.01 ± 0.14 (min times µg)/(pmol times µl)) and an ordinate intercept of 45.9 ± 8.8 min/pmol from which K = 0.044 µg/µl and V(max) = 2.2 nmol/(min times mg) were calculated, respectively. Aliquots of the phosphorylation were subjected to phosphoamino acid analysis (inset).



Regulation of the Protein Kinase Activity of Dyrk by Tyrosine Phosphorylation in the Putative Activation Domain

Dyrk contains 2 tyrosine residues between the subdomains VII and VIII (Fig. 1A and Fig. 7). Similar residues are present in other kinases (Fig. 7) (Rossomando et al., 1992; Han et al., 1994; Derijard et al., 1994; Hughes et al., 1993), which have recently been shown to be phosphorylated, giving rise to activation of the enzymes. Consequently, the domain is believed to be crucial for the regulation of these kinases (Marshall, 1994). Since we suspected a similar pattern of regulation of Dyrk, constructs were generated encoding mutants of Dyrk, and the resulting recombinant proteins were tested for their kinase activities. As is illustrated in Fig. 8, exchange of the two tyrosines in the activation loop (GST-Dyrk-Y319/321F in lane 4) suppressed the autophosphorylation of Dyrk on tyrosine (panel A) as well as its kinase activity (tyrosine and serine/threonine) toward histone (panel B). Exchange of Tyr-219 for phenylalanine largely reduced the autophosphorylation of Dyrk on tyrosine, as detected with anti-phosphotyrosine antibody, but failed to significantly reduce the histone phosphorylation. As an additional control, a kinase-negative mutant (Dyrk-K188R) was constructed by exchange of the conserved lysine in the ATP-binding motif. Like that of Dyrk-Y319F/Y321F, the kinase activity of the resulting recombinant protein was considerably lower than that of Dyrk. Longer exposure (data not shown) revealed that both Dyrk-Y319F/Y321F and Dyrk-K188R retained a minute kinase activity toward histone. A low residual kinase activity of constructs similar to Dyrk-K188R has previously been reported for several other kinases (Zhou and Elledge, 1993; Brill et al., 1994; Bowdish et al., 1994). These data indicate that Tyr-219 and Tyr-319/Tyr-321 are autophosphorylated, and that the tyrosines in the activation loop regulate the protein kinase activity of Dyrk.


Figure 8: Autophosphorylation and protein kinase activities of Dyrk-mutants of tyrosines 219 and 319/321. Tyrosine residues Tyr-219 and Tyr-319/Tyr-321 were substituted for phenylalanine; Lys-188 was exchanged for arginine as described under ``Materials and Methods.'' A, the partially purified GST-fusion proteins of Dyrk-wild type and mutants were separated on SDS-PAGE (10% gels), transferred onto nitrocellulose membranes, and phosphotyrosine was detected immunochemically with specific antibody. In parallel experiments, it was ascertained that equal amounts of the 90-kDa fragment were present in each lane. B, partially purified GST-fusion proteins of Dyrk-wild type and mutants were phosphorylated in vitro as described in the presence of histone, and reaction products were separated by SDS-PAGE (14% gels). The gel was dried and autoradiographed for 18 h. Equal amounts of the 90-kDa fragments were present in each lane.




DISCUSSION

The present data indicate that Dyrk is a dual specificity protein kinase that catalyzes its autophosphorylation on both serine/threonine and tyrosine residues. Moreover, the data give a first insight into the regulation of Dyrk. Its kinase activity depends on the presence of tyrosine residues between subdomains VII and VIII (activation loop, Fig. 7). Thus, in analogy to the serine/threonine kinases ERK2 (Payne et al., 1991; Rossomando et al., 1992), GSK3beta (Hughes et al., 1993), JNK1 (Derijard et al., 1994), and p38 (Han et al., 1994), the conclusion appears to be justified in that the activation of Dyrk depends on the phosphorylation of one or both of these tyrosines. It should be noted that the activation motif in Dyrk (YQY, see Fig. 7) is somewhat different from that in the other tyrosine-regulated serine kinases, which contain a single tyrosine residue or a tyrosine and a threonine. C-terminal to the YQY motif are three residues (RFY), which are conserved in all other tyrosine phosphorylation-regulated kinases (Fig. 7) and might therefore belong to the activation motif. The YQY motif resembles that present in Mnb (YHY), Yak1 and PSK-H2 (YTY), and we anticipate on the basis of this structural similarity that these kinases are also activated by tyrosine phosphorylation in the activation loop. It remains to be elucidated whether the activation of Dyrk is regulated by a protein kinase or by an activator of autophosphorylation.

Dual specificity protein kinases represent a class of the protein kinase superfamily that is defined solely by their ability to phosphorylate both serine/threonine and tyrosine. The so far identified dual specificity kinases (Clk1, ERK2, GSK3beta, MEK1, TIK, ESK; see Fig. 2A) share no easily recognizable structural similarities other than the domains common for all serine/threonine kinases (Lindberg et al., 1992). Some of these kinases harbor the activation motif as depicted in Fig. 7, others (TIK, ESK, Clk) lack this motif. Thus, at present there are no structural similarities predicting dual specificity. Accordingly, the catalytic domain of Dyrk is only distantly related to those of the other dual specificity kinases. The so far characterized dual specificity kinases show different functional characteristics (Lindberg et al., 1992). Some can use poly-Glu/Tyr as a substrate, others do not. Some dual specificity kinases catalyze tyrosine phosphorylation exclusively as autophosphorylation (ERK2, Wu et al.(1991); GSK3beta, Wang et al.(1994)), others can stimulate both autophosphorylation and phosphorylation of exogenous substrates on tyrosine (e.g. MEK, Zheng and Guan(1993)). Dyrk appears unique in that it catalyzed both autophosphorylation and histone phosphorylation on tyrosine, but it failed to phosphorylate poly-Glu/Tyr. Thus, the substrates of Dyrk appear to require specific consensus motifs, which may not be identical with those of other kinases.

Dyrk exhibits several striking structural characteristics of potential functional relevance. The sequence harbors a bipartite nuclear targeting motif at amino acids 117-134 that consists of 2 basic amino acids, a spacer of 10 amino acids, and 4 additional basic amino acids. Similar motifs have previously been found in a number of nuclear proteins, e.g. steroid hormone receptors, transcription factors, and enzymes and proteins involved in transcription or mitosis (Dingwall and Laskey, 1991). This motif appears to be a reliable indicator of nuclear localization since it is found in about 50% of nuclear proteins but in less than 5% of nonnuclear proteins.

The region of Dyrk flanking the C terminus of its catalytic domain contains an unusual portion of uncharged hydrophilic amino acids (31 threonines and 46 serines in a total of 284 amino acids). A computerized search revealed that a portion of this region immediately following the catalytic domain fulfilled the requirement of a PEST region (Rogers et al., 1986). Because PEST regions are typical of rapidly metabolized proteins, they are believed to signal their degradation (Rogers et al., 1986). The PEST region in Dyrk showed a score that would rank second among those listed (Rogers et al., 1986). In addition to the PEST region, the C-terminal portion of Dyrk harbors a repeat of 13 histidines (amino acids 607-619) and a stretch of 13 subsequent serine/threonine residues (amino acids 659-672). A data base search revealed that similar histidine repeats have previously been found in other proteins, e.g. a protein kinase from yeast (SNF1, Celenza and Carlson, 1986) and several transcription factors (e.g. accession no. P39020, P15463, and P25490), but their exact function is as yet unclear.

At present, we can only speculate on the possible function of Dyrk on the basis of its structural features and its autophosphorylation on tyrosine residues. The closest relative of Dyrk is the product of the mnb gene from Drosophila with 85% identical amino acids within the catalytic domain (Tejedor et al., 1995). It appears reasonable to assume that Dyrk is the mammalian homologue of this gene, although it exhibited several striking differences outside the catalytic domains. mnb appears to be involved in postembryonic neurogenesis because the gene was found disrupted in the minibrain mutant (Tejedor et al., 1995). Another relative of Dyrk, Yak1, has been suggested to arrest cell growth in yeast because its inactivation allowed growth deficient strains to proliferate (Garrett and Broach, 1989; Garrett et al., 1991). Based on the unproven assumption that the structural similarities reflect a functional relationship, it might be speculated that Dyrk is involved in cell cycle control. All other kinases that are regulated by tyrosine phosphorylation between subdomains VII and VIII, e.g. MAPK/ERK, JNK, and GSK3beta, are components of signaling pathways that transduce receptor-initiated signals to a nuclear phosphorylation of transcription factors (Hill and Treisman, 1995; Woodgett, 1991). By analogy, we speculate that Dyrk is a component of a similar signaling pathway, possibly mediating the specific phosphorylation of transcription factors within the nucleus.


FOOTNOTES

*
This work was supported by Grant Jo 117/6-2 from the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank(TM)/EMBL Data Bank with accession number(s) X79769[GenBank].

§
Contributed equally to this paper.

Present address: Inst. of Medical Technology, University of Tampere, Finland.

**
To whom correspondence should be addressed: Institut für Pharmakologie und Toxikologie, Medizinische Fakultät der RWTH Aachen, Wendlingweg 2, D-52057 Aachen, Germany. Tel.: 49-241-8089120; Fax: 49-241-8888433; :joost{at}rwth-aachen.de.

(^1)
The abbreviations used are: MAP, mitogen-activated protein; PCR, polymerase chain reaction; bp, base pair(s); PAGE, polyacrylamide gel electrophoresis; PVDF, polyvinylene difluoride; GST, glutathione S-transferase.


ACKNOWLEDGEMENTS

We thank B. Feulner for skillful technical assistance.


REFERENCES

  1. Becker, W., Kentrup, H., Klumpp, S., Schultz, J. E., and Joost, H. G. (1994) J. Biol. Chem. 269, 22586-22592 [Abstract/Free Full Text]
  2. Bowdish, K. S., Yuan, H. E., and Mitchell, A. P. (1994) Mol. Cell. Biol. 14, 7909-7919 [Abstract]
  3. Brill, J. A., Elion, E. A., and Fink, G. R. (1994) Mol. Biol. Cell 5, 297-312 [Abstract]
  4. Celenza, J. L., and Carlson, M. (1986) Science 233, 1175-1180 [Medline] [Order article via Infotrieve]
  5. Cheng, J.-F., Boyartchuk, V., and Zhu, Y. (1994) Genomics 23, 75-84 [CrossRef][Medline] [Order article via Infotrieve]
  6. Cohen, P. (1992) Trends Biochem. Sci. 17, 408-413 [Medline] [Order article via Infotrieve]
  7. Cooper, J. A., Esch, F. S., Taylor, S. S., and Hunter, T. (1984) J. Biol. Chem. 259, 7835-7841 [Abstract/Free Full Text]
  8. Derijard, B., Hibi, M., Wu, I., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. (1994) Cell 76, 1025-1037 [Medline] [Order article via Infotrieve]
  9. Dingwall, C., and Laskey, R. A. (1991) Trends Biochem. Sci. 16, 478-481 [Medline] [Order article via Infotrieve]
  10. Edelman, A. M., Blumenthal, D. K., and Krebs, E. G. (1987) Annu. Rev. Biochem. 56, 567-613 [CrossRef][Medline] [Order article via Infotrieve]
  11. Feinberg, A. P., and Vogelstein, B. (1983) Anal. Biochem. 132, 6-13 [Medline] [Order article via Infotrieve]
  12. Ferrell, J. E., and Martin, G. S. (1991) Methods Enzymol. 200, 430-435 [Medline] [Order article via Infotrieve]
  13. Garrett, S., and Broach, J. (1989) Genes & Dev. 3, 1336-1348
  14. Garrett, S., Menold, M. M., and Broach, J. R. (1991) Mol. Cell. Biol. 11, 4045-4052 [Medline] [Order article via Infotrieve]
  15. Green, H., and Kehinde, O. (1974) Cell 1, 113-116
  16. Han, J., Lee, J.-D., Bibbs, L., and Ulevitch, R. J. (1994) Science 265, 808-811 [Medline] [Order article via Infotrieve]
  17. Hanks, S. K., and Quinn, A. M. (1991) Methods Enzymol. 200, 38-62 [Medline] [Order article via Infotrieve]
  18. Hanks, S. K., Quinn, A. M., and Hunter, T. (1988) Science 241, 42-52 [Medline] [Order article via Infotrieve]
  19. Hill, C. S., and Treisman, R. (1995) Cell 80, 199-211 [Medline] [Order article via Infotrieve]
  20. Hughes, K., Nikolakaki, E., Plyte, S. E., Totti, N. F., and Woodgett, J. R. (1993) EMBO J. 12, 803-808 [Abstract]
  21. Hunter, T. (1987) Cell 50, 823-829 [Medline] [Order article via Infotrieve]
  22. Hunter, T. (1991) Methods Enzymol. 200, 3-37 [Medline] [Order article via Infotrieve]
  23. Kornbluth, S., Paulson, K. E., and Hanafusa, H. (1988) Mol. Cell. Biol. 8, 5541-5544 [Medline] [Order article via Infotrieve]
  24. Kunkel, T. A., Roberts, J. D., and Zakour, R. A. (1987) Methods Enzymol. 154, 367-382 [Medline] [Order article via Infotrieve]
  25. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  26. Lindberg, R. A., Quinn, A. M., and Hunter, T. (1992) Trends Biochem. Sci. 17, 114-119 [Medline] [Order article via Infotrieve]
  27. Lundgren, K., Walworth, N., Booher, R., Dembski, M., Kirschner, M., and Beach, D. (1991) Cell 64, 1111-1122 [Medline] [Order article via Infotrieve]
  28. Marshall, C. J. (1994) Nature 367, 686 [Medline] [Order article via Infotrieve]
  29. Payne, D. M., Rossomando, A. J., Martino, P., Erickson, A. K., Her, J. H., Shabanowitz, J., Hunt, D. F., Weber, M. J., and Sturgill, T. W. (1991) EMBO J. 10, 885-92 [Abstract]
  30. Robbins, J., Dilworth, S. M., Laskey, R. A., and Dingwall, C. (1991) Cell 64, 615-623 [Medline] [Order article via Infotrieve]
  31. Rogers, S., Wells, R., and Rechsteiner, M. (1986) Science 234, 364-368 [Medline] [Order article via Infotrieve]
  32. Rossomando, A. J., Wu, J., Shabanowitz, J., Hunt, D. F., Weber, M. J., and Sturgill, T. M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5779-5783 [Abstract]
  33. Tejedor, F., Zhu, X. R., Kaltenbach, E., Ackermann, A., Baumann, A., Canal, I., Heisenberg, M., Fischbach, K. F., and Pongs, O. (1995) Neuron 14, 287-301 [Medline] [Order article via Infotrieve]
  34. Wandel, S., Schürmann, A., Becker, W., Summers, S. A., Shanahan, M. F., and Joost, H. G. (1994) FEBS Lett. 348, 114-118 [CrossRef][Medline] [Order article via Infotrieve]
  35. Wang, Q. M., Fiol, C. J., DePaoli-Roach, A. A., and Roach, P. J. (1994) J. Biol. Chem. 269, 14566-14574 [Abstract/Free Full Text]
  36. Weiland, M., Bahr, F., Höhne, M., Schürmann, A., Ziehm, D., and Joost, H. G. (1991) J. Cell. Physiol. 149, 428-435 [Medline] [Order article via Infotrieve]
  37. Woodgett, J. R. (1991) Trends Biochem. Sci. 16, 177-181 [Medline] [Order article via Infotrieve]
  38. Wu, J., Rossomando, A. J., Her, J. H., del Vecchio, R., Weber, M. W., and Sturgill, T. W. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9508-9512 [Abstract]
  39. Yuan, C. J., Huang, C. Y. F., and Graves, D. J. (1993) J. Biol. Chem. 268, 17683-17686 [Abstract/Free Full Text]
  40. Zheng, C. F., and Guan, K. L. (1993) J. Biol. Chem. 268, 23933-23939 [Abstract/Free Full Text]
  41. Zhou, Z., and Elledge, S. J. (1993) Cell 75, 1119-1127 [Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.